Company announces name change to SRX Global in conjunction with transaction closingCompany’s stock to remain trading on the NYSE American ...

FDA's early-stage clinical trial program, a mysterious single patient gets retatrutide access, and more health news from ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a decade, ...

Forbes Health’s content is supported by our Forbes Health Advisory Board. This panel of board-certified, experienced physician experts helps to review our articles on medical supplies and provides ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience. The ...

Perhaps more than any American President in recent memory, Donald Trump has made lowering drug prices a major priority for his administration. What’s referred to as his “Most-Favoured Nations” or MFN ...

It’s new and ready for you to read first thing EVERY morning, seven days a week. Take a look at this short video which shows you all of its features and benefits.